Risks of Colonoscopy with Age

Colorectal cancer (CRC) remains one of the most common and preventable cancers. Screening plays a crucial role in detecting it early or preventing it altogether by identifying and removing precancerous
Medicare Premiums Increase in 2026

The Centers for Medicare & Medicaid Services (CMS) has just rolled out the latest adjustments for Medicare Parts A and B, effective January 1, 2026. If you’re enrolled in Medicare
The Latest on Canada-US Tariffs

The U.S. suspension of the duty-free “de minimis” threshold for low-value shipments, which took effect on August 29, 2025, continues to reshape cross-border shopping from Canada.
Balance Your Blood Pressure

High blood pressure, or hypertension, affects millions worldwide and is a major risk factor for heart disease, stroke, and kidney issues.
Trump Policies Push Doctors to Canada

A prominent Ottawa heart surgeon, Dr. Marc Ruel, had planned to join the University of California, San Francisco, to lead their heart surgery division.
New U.S. Duty Rules

What Shoppers Need to Know Starting August 29, 2025, shopping from Canadian businesses and shipping to the U.S. will come with some changes due to new U.S. customs regulations. The
Health Systems Brace for Medicaid Cuts

Hospitals, health systems, and physician practices are recalibrating their operational and financial strategies to navigate evolving federal regulations, according to a recent KLAS Research survey.
Helping Patients Navigate Medicaid Cuts

Recent federal budget cuts signed into law by President Donald Trump are set to impact healthcare access significantly. Over the next decade, the Congressional Budget Office projects that approximately 12
US Employers Shift Benefits Costs

A 2025 Mercer survey of over 500 large U.S. employers (500+ employees) indicates significant changes in employee benefits for 2026, with a focus on cost management and innovative healthcare solutions.
Novo Nordisk’s Patent Lapse Opens Door For Generics

Hims & Hers Health, a U.S.-based telehealth platform, plans to enter the Canadian market in 2026, offering generic semaglutide drugs following the expiration of Novo
Medicaid Cut Care Solutions

On July 4, 2025, President Donald Trump signed the One Big Beautiful Bill Act (OBBBA) into law, enacting sweeping changes to the U.S. healthcare system. The legislation, passed by a
AI Tool Enhances Personalized Cancer Care

A groundbreaking AI tool, AAnet, developed by a multinational research team led by the Garvan Institute of Medical Research and Yale University, is poised to transform cancer treatment.
How Obesity Accelerates Health Risks and Pain

Obesity, defined as a body mass index (BMI) of 30 or higher, is a significant public health concern linked to over 200 comorbidities, ranging from musculoskeletal pain to cardiometabolic and
Supplements to Consider with Meds Like Ozempic and Mounjaro

GLP-1 medications, such as Ozempic (semaglutide) and Mounjaro, are widely used for managing Type 2 diabetes and obesity. These medications can reduce appetite, which may lead to lower nutrient intake,
Medicaid Reforms Pass House in Budget Bill

On May 22, 2025, the House of Representatives passed H.R. 119, the “One Big Beautiful Bill Act,” in a razor-thin 215-214 vote, with only Republican support. Championed by President Donald
